Vattulainen, Meri
Ilmarinen, Tanja
Viheriälä, Taina
Jokinen, Vilma
Skottman, Heli http://orcid.org/0000-0002-4127-8792
Funding for this research was provided by:
Academy of Finland (297886)
Sigrid Juséliuksen Säätiö
Suomen Kulttuurirahasto
Silmä- ja kudospankkisäätiö
Article History
Received: 27 September 2021
Accepted: 6 December 2021
First Online: 20 December 2021
Declarations
:
: Tampere University, Faculty of Medicine and Health Technology, has the approval of the National Authority Fimea (Dnro FIMEA/2020/003758) to conduct research on human embryos. The research group also has supportive statements of the Ethical Committee of the Pirkanmaa Hospital District to derive, culture, and differentiate hESC lines (R05116), to establish and use hiPSC lines in ophthalmic research (R16116), and to use human corneas which are not suitable for transplantation in research (R11134). No new hESC or hiPSC lines were made for this study. The porcine corneas used in this study were acquired from the local abattoir as a side product and were thus not the sole reason for animal sacrifice.
: Not applicable.
: TI and HS are co-inventors of a pending patent transferred from Tampere University (Tampere, Finland) to StemSight Ltd (Tampere, Finland) regarding the cell production technology used herein. Based on the Act on the Right in Inventions made at Higher Education Institutions in Finland, all authors employed by Tampere University have given all rights to the University and thus have declared no competing interests. TI and HS are co-founders and shareholders in StemSight Ltd. The other authors declare no conflicts of interests.